Sinapis Pharma's Unattributed Round

Sinapis Pharma raised a round of funding on April 24, 2014.

Sinapis Pharma is a discovery stage biotechnology company that has identified and has patents-pending for a new use and route of administration for its lead compound, Methamphetamine, an FDA-approved …

Articles about Sinapis Pharma's Unattributed Round: